HIV drug created at UNC generates buzz
12th Sep 2005, 04:36 GMT
CHAPEL HILL - Scientists and investors alike are closely watching the development of a new HIV drug, based on a discovery at the University of North Carolina at Chapel Hill, that could revolutionize the way the virus that causes AIDS is treated.
Latest news from bizjournals.com Health Care:Pharmaceuticals headlines:
- United BioSource makes 10th buy, looks for more
- Nonprofits starting to invest in drug companies
- Accentia making changes to its business formula, market focus
- GSK terminates agreement for Genaera frog product
- Gladstone and Merck team to bring drugs to market
- Abbott expects to double vascular business sales
- Mayo to shut down drug-testing unit
- MIT, Dana-Farber win major cancer grants
- Service Bancorp chair resigns
- Introgen strikes nanotech deal with M.D. Anderson